Because ITUB has rallied sharply, its published analyst targets no longer provide a meaningful upside from which to build a central target. The verified 12-month targets used by major aggregators average roughly $9.03 (S&P Global data across eight analysts) to $9.87 (five analysts per MarketBeat), with individual firm targets ranging from an older low near $6 to a high of $10.50 set by Goldman Sachs on October 9, 2026. JPMorgan analyst Domingos Falavina holds an Overweight rating with a $10 target, while HSBC analyst Carlos Gomez-Lopez downgraded the shares to Hold with a $9.10 target on October 8, 2026, citing valuation.
Because the overall average sits essentially at the current market price, the analyst methodology fails the requirement that a central target be at least 10% above the latest price. The $11 figure used here is therefore a fallback objective grounded in public discussion and technical milestones — specifically, a round-number psychological level that would clear the stock's 52-week high and its prior decade peak — rather than a formal analyst price forecast.
As of the close of trading on October 20, 2026, ITUB traded near $9.72, up about 3% on the day after closing at $9.43 the prior session. The shares carry a 52-week range of $6.80 to $10.20, meaning the stock is trading within roughly 5% of its recent high. Reaching $11 would require a move of about 13% — a substantial, though not extreme, gain that would also take the ADR to a fresh decade high, above the prior peak near $10.29 reached in early 2018.
The stock's path to that level would likely depend on continued delivery of the bank's strong profitability, sustained credit discipline, and a supportive Brazilian macro backdrop. ITUB trades near a price-to-earnings (P/E) ratio of about 12 on trailing earnings and roughly 10 on forward estimates, leaving some room for multiple expansion if earnings keep compounding.
Itaú's fundamentals are among the strongest in Latin American banking. The company has maintained a return on equity near 21%, an efficiency ratio near historic lows, and nonperforming-loan levels that have stayed stable even as broader Brazilian credit conditions tightened. Recent quarterly results showed double-digit year-over-year growth in recurring net income, supported by resilient net interest income, growing fee and insurance revenue, and disciplined cost control.
Broader conditions could also help. Falling or stabilizing Brazilian interest rates typically support loan growth and reduce funding costs, while a stronger Brazilian real can translate directly into higher U.S.-dollar ADR prices. Robust dividend payouts and share buybacks add further shareholder support.
The most immediate obstacle is valuation and positioning. After a roughly 55% one-year return and a 37% year-to-date gain, much of the bank's recent improvement is already reflected in the share price — a point emphasized by HSBC's recent downgrade to Hold. With the average analyst target now at or below the current price, upside conviction on the sell side has narrowed meaningfully.
Other risks include renewed inflationary pressure in Brazil forcing the central bank to keep rates higher for longer, weaker-than-expected credit demand, margin compression in a competitive lending market, and adverse currency moves that erode the dollar value of the ADR. A broad rotation away from emerging-market financials could also act as a headwind.
ITUB's recent 52-week high of $10.20, set on October 6, 2026, now functions as the key resistance level to clear before any move toward $11. The prior decade high near $10.29 adds another layer of overhead supply. On the downside, the 50-day moving average near $8.33 and the 200-day moving average near $8.20 represent important support levels, with the round $9 figure sitting just below the current price as a near-term psychological floor. A decisive break above $10.20–$10.30 on strong volume would be the technical signal most consistent with a continued advance toward the $11 round-number objective.
Although most analyst price targets reflect a roughly 12-month research horizon, the $11 milestone discussed here carries no fixed time frame and should be viewed as a technical and valuation benchmark rather than a dated forecast. Investors should watch the company's next earnings report, scheduled for early November 2026, along with management's guidance on credit growth, margins, and capital returns. Brazilian inflation data, central bank rate decisions, and the path of the real against the dollar are equally important, as are any further analyst revisions — upgrades or downgrades — in the wake of the stock's rapid run.
Traders seeking an edge in timing entries and exits can turn to Tickeron's AI Daily Buy/Sell Signals. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This can help traders discover new opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening alone. For investors tracking ITUB and similar financial names, these signals offer a structured way to stay ahead of momentum shifts.
Can ITUB reach $11? The move would require a gain of roughly 13% from the latest price near $9.72 and would push the ADR to a fresh decade high. The bank's strong ROE, disciplined credit culture, and resilient earnings provide a credible foundation, while falling Brazilian rates and a firmer real could add tailwinds. However, the case is far from one-sided: the stock has already risen sharply, the average analyst target no longer sits above the market price, and a recent Hold downgrade underscores valuation concerns. Reaching $11 is plausible if earnings continue to compound and macro conditions cooperate, but it is by no means assured, and the $10.20–$10.30 resistance zone represents the first meaningful test.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ITUB has been loosely correlated with INTR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ITUB jumps, then INTR could also see price increases.
| Ticker / NAME | Correlation To ITUB | 1D Price Change % | ||
|---|---|---|---|---|
| ITUB | 100% | +2.86% | ||
| INTR - ITUB | 64% Loosely correlated | +5.22% | ||
| LYG - ITUB | 47% Loosely correlated | N/A | ||
| KB - ITUB | 46% Loosely correlated | +0.51% | ||
| SHG - ITUB | 44% Loosely correlated | +0.26% | ||
| AVAL - ITUB | 43% Loosely correlated | +2.76% | ||
More | ||||
| Ticker / NAME | Correlation To ITUB | 1D Price Change % |
|---|---|---|
| ITUB | 100% | +2.86% |
| ITUB (3 stocks) | 65% Loosely correlated | +3.30% |
| Banks (430 stocks) | 1% Poorly correlated | +1.14% |
| Regional Banks (357 stocks) | -1% Poorly correlated | +1.36% |